Expert Review of Neurotherapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.3 | Q1 | 81.1% | 1.106 | Q1 | 86.4% |
| 2024 | 3.4 | Q2 | 73.0% | 1.162 | Q1 | 87.7% |
| 2023 | 3.4 | Q2 | 71.3% | 0.957 | Q1 | 84.4% |
| 2022 | 4.3 | Q2 | 73.9% | 0.995 | Q1 | 86.1% |
| 2021 | 4.3 | Q2 | 72.1% | 1.020 | Q1 | 87.0% |
| 2020 | — | — | 1.187 | Q1 | 88.8% | |
| 2019 | — | — | 1.101 | Q1 | 87.7% | |
| 2018 | — | — | 1.064 | Q1 | 85.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-8360
ISSN
1473-7175
country
GBcoverage
2001-2026